Akeso Announced Enrollment of First Patient in Phase 3 Trial of Cadonilimab for Consolidation Therapy After Concurrent or Sequential Chemoradiotherapy in NSCLC
HONG KONG, Feb. 13, 2025 /PRNewswire/ -- Akeso, Inc. (9926. HK) ("Akeso" or the "Company") announced the recent completion of the first patient enrollment in the Phase 3 randomized, double-blind, multicenter clinical trial (COMPASSION-30/AK104-309)...
NaaS Technology Inc. to Participate in Upcoming Investor Conferences in February 2025
BEIJING, Feb. 12, 2025 /PRNewswire/ -- NaaS Technology Inc. (Nasdaq: NAAS) ("NaaS" or the "Company"), the first U.S.-listed EV charging service company in China, today announced that management will participate in the following upcoming investor...
Experion Technologies and Tagit Join Forces to Transform Digital Banking Solutions
LONDON and SINGAPORE, Feb. 11, 2025 /PRNewswire/ -- Experion Technologies, a global software product engineering and digital transformation company, has announced a strategic partnership with Tagit, an award-winning digital banking solutions...
LOTTE BIOLOGICS to Present at the 2025 J.P. Morgan Healthcare Conference
New CEO James Park Delivers First Presentation at J.P. Morgan Healthcare Conference on "Advancing as a Global CDMO Leader" Unveiling of Next-Generation ADC Platform 'SoluFlex Link': Enabling High-Potency, High-Yield ADC Development and Manufacturing...
Ridgewood Infrastructure Announced $1.2 Billion Final Close for Fund II, Significantly Surpassing Its Target
NEW YORK, Jan. 16, 2025 /PRNewswire/ -- Ridgewood Infrastructure ("Ridgewood"), a leading investor in essential infrastructure in the U.S. lower middle market, today announced the final close of its second fund, Ridgewood Water & Strategic...
EHGO and Zhenjiang High-tech Zone to Jointly Build an AI Data Center and Supply Chain Center for Office Solutions
SHANGHAI, Jan. 13, 2025 /PRNewswire/ -- Eshallgo Inc ("Eshallgo" or the "Company") (NasdaqCM: EHGO), one of the leading Chinese office integrator, agent, and service provider, today announced that on January 10th, 2025, Eshallgo, a company listed on...
Menarini Group and Insilico Medicine Enter a Second Exclusive Global License Agreement for an AI Discovered Preclinical Asset Targeting High Unmet Needs in Oncology
This is the second asset Menarini Group has inlicensed from Insilico Medicine which was discovered through their generative AI platform, similar to the preclinical stage KAT6 inhibitor (MEN2312) licensed a year ago and which advanced rapidly into...
EastWest Bank and MoEngage Join Hands to Power Innovative and Customer-Centric Banking
SAN FRANCISCO, Jan. 8, 2025 /PRNewswire/ -- EastWest Bank is committed to innovation and excellence in retail, corporate, and consumer finance. As a recognized leader in personalized financial solutions, EastWest has shaped its services to ensure...
Mega Matrix Inc. Announced that the English Version of "Drink Me, Keep Me, Cut Me" Premiered on FlexTV
SINGAPORE, Jan. 6, 2025 /PRNewswire/ -- Mega Matrix Inc. (NYSE American: MPU) announced that its globally renowned short drama streaming platform, FlexTV, premiered short drama Drink Me, Keep Me, Cut Me, the English adaptation of <无心之术>,...
Alphamab Oncology Announced Anti-HER2 Bispecific ADC JSKN003 Received Approval from CDE to Initiate a Phase III Clinical Study for Ovarian Cancer
SUZHOU, China, Dec. 27, 2024 /PRNewswire/ -- Alphamab Oncology (stock code: 9966.HK) announced that anti-HER2 bispecific antibody-drug conjugate (ADC) JSKN003 has received approval from the Center for Drug Evaluation (CDE) of the National Medical...